BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33196194)

  • 1. Analysis of NIST Monoclonal Antibody Reference Material Glycosylation Using the LC-MS/MS-Based Glycoproteomic Approach.
    Zhao J; Peng W; Dong X; Mechref Y
    J Proteome Res; 2021 Jan; 20(1):818-830. PubMed ID: 33196194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody.
    Falck D; Thomann M; Lechmann M; Koeleman CAM; Malik S; Jany C; Wuhrer M; Reusch D
    MAbs; 2021; 13(1):1865596. PubMed ID: 33382957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Traditional 2-AB Fluorescence LC-MS/MS and Automated LC-MS for the Comparative Glycan Analysis of Monoclonal Antibodies.
    Schiel JE; Rogstad SM; Boyne MT
    J Pharm Sci; 2015 Aug; 104(8):2464-72. PubMed ID: 26053232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycan characterization of the NIST RM monoclonal antibody using a total analytical solution: From sample preparation to data analysis.
    Hilliard M; Alley WR; McManus CA; Yu YQ; Hallinan S; Gebler J; Rudd PM
    MAbs; 2017; 9(8):1349-1359. PubMed ID: 28895795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of Herceptin N-Linked glycosylation by HILIC-FLD and LC-MS/MS methods.
    Rauniyar N; Khetani J; Han X
    J Pharm Biomed Anal; 2024 Jul; 244():116123. PubMed ID: 38554555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods.
    De Leoz MLA; Duewer DL; Fung A; Liu L; Yau HK; Potter O; Staples GO; Furuki K; Frenkel R; Hu Y; Sosic Z; Zhang P; Altmann F; Grunwald-Grube C; Shao C; Zaia J; Evers W; Pengelley S; Suckau D; Wiechmann A; Resemann A; Jabs W; Beck A; Froehlich JW; Huang C; Li Y; Liu Y; Sun S; Wang Y; Seo Y; An HJ; Reichardt NC; Ruiz JE; Archer-Hartmann S; Azadi P; Bell L; Lakos Z; An Y; Cipollo JF; Pucic-Bakovic M; Štambuk J; Lauc G; Li X; Wang PG; Bock A; Hennig R; Rapp E; Creskey M; Cyr TD; Nakano M; Sugiyama T; Leung PA; Link-Lenczowski P; Jaworek J; Yang S; Zhang H; Kelly T; Klapoetke S; Cao R; Kim JY; Lee HK; Lee JY; Yoo JS; Kim SR; Suh SK; de Haan N; Falck D; Lageveen-Kammeijer GSM; Wuhrer M; Emery RJ; Kozak RP; Liew LP; Royle L; Urbanowicz PA; Packer NH; Song X; Everest-Dass A; Lattová E; Cajic S; Alagesan K; Kolarich D; Kasali T; Lindo V; Chen Y; Goswami K; Gau B; Amunugama R; Jones R; Stroop CJM; Kato K; Yagi H; Kondo S; Yuen CT; Harazono A; Shi X; Magnelli PE; Kasper BT; Mahal L; Harvey DJ; O'Flaherty R; Rudd PM; Saldova R; Hecht ES; Muddiman DC; Kang J; Bhoskar P; Menard D; Saati A; Merle C; Mast S; Tep S; Truong J; Nishikaze T; Sekiya S; Shafer A; Funaoka S; Toyoda M; de Vreugd P; Caron C; Pradhan P; Tan NC; Mechref Y; Patil S; Rohrer JS; Chakrabarti R; Dadke D; Lahori M; Zou C; Cairo C; Reiz B; Whittal RM; Lebrilla CB; Wu L; Guttman A; Szigeti M; Kremkow BG; Lee KH; Sihlbom C; Adamczyk B; Jin C; Karlsson NG; Örnros J; Larson G; Nilsson J; Meyer B; Wiegandt A; Komatsu E; Perreault H; Bodnar ED; Said N; Francois YN; Leize-Wagner E; Maier S; Zeck A; Heck AJR; Yang Y; Haselberg R; Yu YQ; Alley W; Leone JW; Yuan H; Stein SE
    Mol Cell Proteomics; 2020 Jan; 19(1):11-30. PubMed ID: 31591262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a Quantitative LC-MS Multiattribute Method for Monitoring Site-Specific Glycan Heterogeneity on a Monoclonal Antibody Containing Two N-Linked Glycosylation Sites.
    Wang T; Chu L; Li W; Lawson K; Apostol I; Eris T
    Anal Chem; 2017 Mar; 89(6):3562-3567. PubMed ID: 28199092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of glycosylation in monoclonal antibodies and its importance in therapeutic antibody development.
    Kaur H
    Crit Rev Biotechnol; 2021 Mar; 41(2):300-315. PubMed ID: 33430641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry Characterization of Higher Order Structural Changes Associated with the Fc-glycan Structure of the NISTmAb Reference Material, RM 8761.
    Groves K; Cryar A; Cowen S; Ashcroft AE; Quaglia M
    J Am Soc Mass Spectrom; 2020 Mar; 31(3):553-564. PubMed ID: 32008322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies.
    Aoyama M; Hashii N; Tsukimura W; Osumi K; Harazono A; Tada M; Kiyoshi M; Matsuda A; Ishii-Watabe A
    MAbs; 2019 Jul; 11(5):826-836. PubMed ID: 30990348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Proteomic and Glycoproteomic Analyses of Prostate Cancer Cells Reveal Glycoprotein Alteration in Protein Abundance and Glycosylation.
    Shah P; Wang X; Yang W; Toghi Eshghi S; Sun S; Hoti N; Chen L; Yang S; Pasay J; Rubin A; Zhang H
    Mol Cell Proteomics; 2015 Oct; 14(10):2753-63. PubMed ID: 26256267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-Glycoproteomic analysis of engineered heavily glycosylated fusion proteins using nanoHILIC-MS.
    Cavallero GJ; Wang Y; Nwosu C; Gu S; Meiyappan M; Zaia J
    Anal Bioanal Chem; 2022 Nov; 414(27):7855-7863. PubMed ID: 36136114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
    Thaysen-Andersen M; Packer NH
    Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of therapeutic antibody glycoforms after subcutaneous and intravenous injection in a porcine model.
    Falck D; Lechmann M; Momčilović A; Thomann M; Koeleman CAM; Jany C; Malik S; Wuhrer M; Reusch D
    MAbs; 2022; 14(1):2145929. PubMed ID: 36383465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of N-Glycopeptide to Released N-Glycan Abundances and the Influence of Glycopeptide Mass and Charge States on N-Linked Glycosylation of IgG Antibodies.
    Remoroza CA; Burke MC; Mak TD; Sheetlin SL; Mirokhin YA; Cooper BT; Goecker ZC; Lowenthal MS; Yang X; Wang G; Tchekhovskoi DV; Stein SE
    J Proteome Res; 2024 Apr; 23(4):1443-1457. PubMed ID: 38450643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Integrated Strategy Reveals Complex Glycosylation of Erythropoietin Using Mass Spectrometry.
    Guan Y; Zhang M; Gaikwad M; Voss H; Fazel R; Ansari S; Shen H; Wang J; Schlüter H
    J Proteome Res; 2021 Jul; 20(7):3654-3663. PubMed ID: 34110173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
    Hills AE; Patel A; Boyd P; James DC
    Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-MS/MS biopharmaceutical glycoanalysis: identification of desirable reference material characteristics.
    Schiel JE; Au J; He HJ; Phinney KW
    Anal Bioanal Chem; 2012 Jun; 403(8):2279-89. PubMed ID: 22354569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry.
    Gahoual R; Biacchi M; Chicher J; Kuhn L; Hammann P; Beck A; Leize-Wagner E; François YN
    MAbs; 2014; 6(6):1464-73. PubMed ID: 25484058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-Depth Characterization and Spectral Library Building of Glycopeptides in the Tryptic Digest of a Monoclonal Antibody Using 1D and 2D LC-MS/MS.
    Dong Q; Yan X; Liang Y; Stein SE
    J Proteome Res; 2016 May; 15(5):1472-86. PubMed ID: 26990841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.